BioCentury

1:17 AM GMT, Oct 2, 2008
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Clinical News

Idera's IMO-2055 misses RCC endpoint

Idera (NASDAQ:IDRA) said preliminary data from 89 evaluable patients showed

Read the full 102 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.